SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-016548
Filing Date
2022-04-29
Accepted
2022-04-28 19:32:40
Documents
15
Period of Report
2022-04-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20220426.htm   iXBRL 8-K 78313
2 EX-3.1 life-ex31_8.htm EX-3.1 12909
3 EX-10.1 life-ex101_7.htm EX-10.1 108594
4 EX-10.2 life-ex102_6.htm EX-10.2 37946
  Complete submission text file 0001564590-22-016548.txt   412654

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA life-20220426.xsd EX-101.SCH 5701
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20220426_lab.xml EX-101.LAB 20180
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20220426_pre.xml EX-101.PRE 12040
9 EXTRACTED XBRL INSTANCE DOCUMENT life-8k_20220426_htm.xml XML 3683
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 22869216
SIC: 2836 Biological Products, (No Diagnostic Substances)